These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10792299)

  • 1. Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect.
    Castaman G; Eikenboom JC; Missiaglia E; Rodeghiero F
    Br J Haematol; 2000 Mar; 108(4):876-9. PubMed ID: 10792299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
    Castaman G; Tosetto A; Federici AB; Rodeghiero F
    Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
    Castaman G; Eikenboom JC; Contri A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):351-2. PubMed ID: 10959713
    [No Abstract]   [Full Text] [Related]  

  • 5. Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families.
    Castaman G; Giacomelli S; Rodeghiero F
    Acta Haematol; 2009; 121(2-3):106-10. PubMed ID: 19506356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.
    Federici AB; Bucciarelli P; Castaman G; Baronciani L; Canciani MT; Mazzucconi MG; Morfini M; Rocino A; Schiavoni M; Oliovecchio E; Iorio A; Mannucci PM
    Semin Thromb Hemost; 2011 Jul; 37(5):511-21. PubMed ID: 22102194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand Disease type 2M "Vicenza" in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families.
    Schneppenheim R; Federici AB; Budde U; Castaman G; Drewke E; Krey S; Mannucci PM; Riesen G; Rodeghiero F; Zieger B; Zimmermann R
    Thromb Haemost; 2000 Jan; 83(1):136-40. PubMed ID: 10669167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common founder mutation p.P2063S in exon 36 of VWF in 11 unrelated Indian von Willebrand disease (VWD) families.
    Kasatkar P; Ghosh K; Shetty S
    Ann Hematol; 2013 Aug; 92(8):1147-8. PubMed ID: 23354996
    [No Abstract]   [Full Text] [Related]  

  • 9. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited and de novo von Willebrand disease 'Vicenza' in UK families with the R1205H mutation: diagnostic pitfalls and new insights.
    Lester WA; Guilliatt AM; Surdhar GK; Enayat SM; Wilde JT; Willoughby S; Grundy P; Cumming AM; Collins PW; Hill FG
    Br J Haematol; 2006 Oct; 135(1):91-6. PubMed ID: 16925796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene.
    Castaman G; Novella E; Castiglia E; Eikenboom JC; Rodeghiero F
    Thromb Res; 2002 Jan; 105(2):135-8. PubMed ID: 11958803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 von Willebrand disease: application of emerging data to clinical practice.
    Collins PW; Cumming AM; Goodeve AC; Lillicrap D
    Haemophilia; 2008 Jul; 14(4):685-96. PubMed ID: 18510569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin.
    Eikenboom JC; Castaman G; Vos HL; Bertina RM; Rodeghiero F
    Thromb Haemost; 1998 Apr; 79(4):709-17. PubMed ID: 9569178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to DDAVP in children with von Willebrand disease type 2.
    Schneppenheim R; Budde U; Beutel K; Hassenpflug WA; Hauch H; Obser T; Oyen F; Schneppenheim S; Schrum J
    Hamostaseologie; 2009 May; 29(2):143-8. PubMed ID: 19404524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
    Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of inherited von Willebrand disease in 2007.
    Federici AB; Mannucci PM
    Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel candidate mutation (Arg611-->His) in type I 'platelet discordant' von Willebrand's disease with desmopressin-induced thrombocytopenia.
    Castaman G; Eikenboom JC; Rodeghiero F; Briët E; Reitsma PH
    Br J Haematol; 1995 Mar; 89(3):656-8. PubMed ID: 7734373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.